GlassScriptPhysician profile
John William Barnhart
NPI 1407975113
$3,098.75
in general payments reported to CMS, 2019-2025
11 companies · $486 in 2025
The $486 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $192 · 2021: $347 · 2022: $433 · 2023: $690 · 2024: $413 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,006.92 | 2019-2025 | Precision7, Precision 1, Hydrus Microstent |
| Coopervision INC. | $880.62 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $419.00 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $250.07 | 2022-2025 | Infuse |
| Lkc Technologies, INC. | $223.99 | 2023-2025 | |
| Topcon Healthcare, INC. | $108.81 | 2023 | |
| Novartis Pharmaceuticals Corporation | $63.06 | 2022 | |
| Abb Con-Cise Optical Group LLC | $61.11 | 2019 | |
| Lombart Brothers, INC. | $32.00 | 2020 | |
| Visioneering Technologies, INC. | $28.94 | 2019 | |
| Biotissue Holdings INC. | $24.23 | 2020-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barnhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.